Axon Enterprise, Inc. (NASDAQ:AXON) Stock Position Raised by Jones Financial Companies Lllp

Jones Financial Companies Lllp lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 21.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,280 shares of the biotechnology company’s stock after purchasing an additional 1,483 shares during the period. Jones Financial Companies Lllp’s holdings in Axon Enterprise were worth $4,921,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of AXON. US Bancorp DE raised its holdings in Axon Enterprise by 2.3% during the 3rd quarter. US Bancorp DE now owns 12,792 shares of the biotechnology company’s stock worth $5,112,000 after buying an additional 284 shares during the period. Stephens Inc. AR increased its position in shares of Axon Enterprise by 4.9% in the third quarter. Stephens Inc. AR now owns 3,886 shares of the biotechnology company’s stock worth $1,553,000 after acquiring an additional 181 shares in the last quarter. Farther Finance Advisors LLC increased its position in shares of Axon Enterprise by 19.4% in the third quarter. Farther Finance Advisors LLC now owns 875 shares of the biotechnology company’s stock worth $350,000 after acquiring an additional 142 shares in the last quarter. Asset Management One Co. Ltd. raised its holdings in shares of Axon Enterprise by 3.3% during the third quarter. Asset Management One Co. Ltd. now owns 26,642 shares of the biotechnology company’s stock valued at $10,646,000 after acquiring an additional 846 shares during the period. Finally, Martin Investment Management LLC purchased a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $232,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on AXON shares. Barclays set a $726.00 target price on shares of Axon Enterprise and gave the company an “overweight” rating in a research note on Thursday, February 27th. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. The Goldman Sachs Group raised their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Northland Securities lifted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Finally, Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a research report on Thursday, February 20th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now owns 124,243 shares in the company, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 5,146 shares of company stock worth $3,262,847. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

AXON stock opened at $528.28 on Wednesday. The company has a market capitalization of $40.28 billion, a price-to-earnings ratio of 136.51, a P/E/G ratio of 5.17 and a beta of 1.12. The firm has a 50 day moving average of $607.58 and a two-hundred day moving average of $526.43. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.